Large Cap Archives - Page 369 of 437

1 minute read

New Oral COVID-19 Antiviral Might Be Better Than Pfizer’s Paxlovid With Faster Recovery, Fewer Side Effects, Data Shows

December 30, 8:39 AM

A study in China shows that a remdesivir analog, dubbed VV116, is as effective as Pfizer Inc's (NYSE: PFE) oral COVID-19 pill.

GILD

2 minute read

How One Of The Most ‘Woke’ CEOs In The U.S. Went From Unloading Trucks To Earning $25 Million

By AJ Fabino

December 29, 7:05 PM

Carl “Doug” McMillon has spent most of his life working for Walmart Inc (NYSE: WMT).

WMT

5 minute read

Elon Musk Tells Employees Tesla Will Be ‘Most Valuable Company On Earth, Sam Bankman-Fried Set To Enter Plea On Fraud Case, Twitter ‘Should Feel Faster’: Today’s Top Stories

By Vandana Singh

December 29, 8:59 AM

Reuters

$BNB

1 minute read

Novartis Settles Antitrust Cases Related To Generic Entry For Hypertension Drug

By Vandana Singh

December 29, 8:18 AM

Novartis AG (NYSE: NVS) will pay $245 million to end antitrust litigation accusing the company of trying to delay the U.S. launch of generic versions of its Exforge, which treats hypertension to lower blood pressure and reduce the risk of strokes.

CVS

1 minute read

Exxon Mobil Sues European Union In Efforts To Scrap New Windfall Tax On Oil Firms

By Vandana Singh

December 29, 8:14 AM

Exxon Mobil Corp (NYSE: XOM) has reportedly sued the European Union to remove the bloc's new windfall tax on oil groups.

XOM

1 minute read

Lockheed Martin Challenges US Army’s Helicopter Contract To Competitor

By Vandana Singh

December 29, 6:53 AM

Sikorsky, a Lockheed Martin Corp (NYSE:LMT) company, filed a formal protest asking the U.S. Government Accountability Office (GAO) to review the U.S.…

2 minute read

Why Are Tesla And Other Big-Name Stocks Selling Off In December? Here’s 1 Potential Reason

By AJ Fabino

December 28, 3:03 PM

Elon Musk’s Tesla Inc (NASDAQ: TSLA) is down nearly 73% year-to-date, marred by the billionaires' purchase of Twitter, prompting investor uncertainty with regard to its growth assets.

AMC

1 minute read

Gilead Sciences Acquires Jounce Therapeutics Cancer Immunotherapy Program

By Vandana Singh

December 28, 10:14 AM

Gilead Sciences Inc (NASDAQ:GILD) and Jounce Therapeutics Inc (NASDAQ:JNCE) amended their existing license agreement for GS-1811 (formerly JTX-1811), enabling Gilead to…

GILD